
OTS514
CAS No. 1338540-63-8
OTS514( OTS514 | OTS 514 | OTS-514 | OTS514 Hydrochloride )
Catalog No. M23492 CAS No. 1338540-63-8
OTS514 is a potent TOPK inhibitor. OTS514 exhibits a growth-suppressive effect on small cell lung cancer. OTS514 effectively suppressed the growth of SCLC cell lines (IC50: 0.4 ~ 42.6 nM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 96 | In Stock |
![]() ![]() |
5MG | 180 | In Stock |
![]() ![]() |
10MG | 315 | In Stock |
![]() ![]() |
25MG | 635 | In Stock |
![]() ![]() |
50MG | 1000 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameOTS514
-
NoteResearch use only, not for human use.
-
Brief DescriptionOTS514 is a potent TOPK inhibitor. OTS514 exhibits a growth-suppressive effect on small cell lung cancer. OTS514 effectively suppressed the growth of SCLC cell lines (IC50: 0.4 ~ 42.6 nM).
-
DescriptionOTS514 is a potent TOPK inhibitor. OTS514 exhibits a growth-suppressive effect on small cell lung cancer. OTS514 effectively suppressed the growth of SCLC cell lines (IC50: 0.4 ~ 42.6 nM). Treatment with OTS514 suppressed forkhead box protein M1 (FOXM1) activity. OTS514 treatment reduced CD90-positive SCLC cells and showed a higher cytotoxic effect against lung sphere-derived CSC-like SCLC cells.
-
In VitroOTS514 (1.5625-100 nM) induces cell cycle arrest and apoptosis at nanomolar concentrations in a series of human myeloma cell lines (HMCL) and prevents outgrowth of a putative CD138+ stem cell population from multiple myeloma (MM) patient-derived peripheral blood mononuclear cells.Cell Viability Assay Cell Line:Human myeloma cell lines (MM1.S, MM1.R, RPMI 8226, 8226Dox40, KMS34, KMS34CFZ, KMS11, JJN3, LP-1, NCI H929, U266B1)Concentration:1.5625, 3.125, 6.25, 12.5, 25, 50, and 100 nM Incubation Time:72 hours Result:IC50 values ranged from 11.6 to 29.4 nM in parental cell lines, indicating a potent inhibitory effect. Only the RPMI 8226-Dox40 cell line, which overexpresses the multi-drug resistance transporter gene ABCB1, is resistant.
-
In VivoOTS514 (1-5 mg/kg; once a day for 2 weeks; intravenous administration) induces tumor regression in a xenograft model of A549 cells (TOPK-positive lung cancer cells). Animal Model:Female BALB/cSLC-nu/nu mice bearing a xenograft model of A549 cells Dosage:1, 2.5, and 5 mg/kg Administration:Intravenously treated; once every day for 2 weeks Result:Resulted in tumor growth inhibition (TGI) of 5.7, 43.3, and 65.3% on day 15, respectively, without any body weight loss.
-
SynonymsOTS514 | OTS 514 | OTS-514 | OTS514 Hydrochloride
-
PathwayOthers
-
TargetOther Targets
-
RecptorTOPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1338540-63-8
-
Formula Weight364.46
-
Molecular FormulaC21H20N2O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:90 mg/mL?(246.94 mM;?Need ultrasonic)
-
SMILESCC(CN)c(cc1)ccc1-c(c(-c1c2scc1)c(c(C)c1)NC2=O)c1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ikeda Y, Park JH, Miyamoto T, Takamatsu N, Kato T, Iwasa A, Okabe S, Imai Y, Fujiwara K, Nakamura Y, Hasegawa K. T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer. Clin Cancer Res. 2016 Dec 15;22(24):6110-6117. PubMed PMID: 27334838.
molnova catalog



related products
-
Resibufagin
Resibufagin shows strong cytotoxic activity against HeLa cell line.
-
DL-Menthol(b)
DL-Menthol is an organic compound made synthetically or obtained from peppermint or mint oils with flavoring and local anesthetic properties.
-
β-Aminoarteether
β-Aminoarteether (SM934 free base), an orally active derivative of Artemisinin, serves a pivotal role in the research of inflammation and autoimmune disorders, including those related to lupus diseases.